ATE311389T1 - Wirkstoffvorläufer von imidazopyridin-derivaten - Google Patents

Wirkstoffvorläufer von imidazopyridin-derivaten

Info

Publication number
ATE311389T1
ATE311389T1 AT01933769T AT01933769T ATE311389T1 AT E311389 T1 ATE311389 T1 AT E311389T1 AT 01933769 T AT01933769 T AT 01933769T AT 01933769 T AT01933769 T AT 01933769T AT E311389 T1 ATE311389 T1 AT E311389T1
Authority
AT
Austria
Prior art keywords
precursor
imidazopyridine derivatives
imidazopyridine
derivatives
substituents
Prior art date
Application number
AT01933769T
Other languages
English (en)
Inventor
Wolfgang-Alexander Simon
Stefan Postius
Reinhard Huber
Wolfgang Kromer
Joerg Senn-Bilfinger
Wilm Buhr
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE311389T1 publication Critical patent/ATE311389T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT01933769T 2000-03-29 2001-03-28 Wirkstoffvorläufer von imidazopyridin-derivaten ATE311389T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00106695 2000-03-29
PCT/EP2001/003514 WO2001072756A1 (en) 2000-03-29 2001-03-28 Prodrugs of imidazopyridine derivatives

Publications (1)

Publication Number Publication Date
ATE311389T1 true ATE311389T1 (de) 2005-12-15

Family

ID=8168271

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01933769T ATE311389T1 (de) 2000-03-29 2001-03-28 Wirkstoffvorläufer von imidazopyridin-derivaten

Country Status (25)

Country Link
US (2) US20030125327A1 (de)
EP (1) EP1313740B1 (de)
JP (1) JP2003528878A (de)
KR (1) KR100860627B1 (de)
CN (1) CN1214030C (de)
AT (1) ATE311389T1 (de)
AU (1) AU783633B2 (de)
BR (1) BR0109483A (de)
CA (1) CA2404474A1 (de)
CZ (1) CZ20023194A3 (de)
DE (1) DE60115466T2 (de)
DK (1) DK1313740T3 (de)
EA (1) EA005597B1 (de)
ES (1) ES2253376T3 (de)
HR (1) HRP20020854A2 (de)
HU (1) HUP0302331A2 (de)
IL (2) IL151200A0 (de)
MX (1) MXPA02009551A (de)
NO (1) NO20024662L (de)
NZ (1) NZ520837A (de)
PL (1) PL365116A1 (de)
SI (1) SI1313740T1 (de)
SK (1) SK286850B6 (de)
WO (1) WO2001072756A1 (de)
ZA (1) ZA200207637B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20023116A3 (cs) * 2000-03-29 2003-01-15 Altana Pharma Ag Alkylované imidazopyridinové sloučeniny
AU2002210563B2 (en) 2000-10-25 2007-03-01 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
WO2003043614A2 (en) * 2001-11-19 2003-05-30 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
HRP20040834A2 (en) 2002-02-15 2005-06-30 Altana Pharma Ag Tricyclic n-acyl compounds
TWI295575B (en) * 2002-04-24 2008-04-11 Altana Pharma Ag Nitrosated imidazopyridines
WO2003094967A2 (en) * 2002-05-07 2003-11-20 Altana Pharma Ag New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
HRP20050528A2 (en) 2002-11-19 2006-06-30 Altana Pharma Ag 8-substituted imidazopyridines
PL375933A1 (en) * 2002-12-20 2005-12-12 Altana Pharma Ag 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines
BRPI0407541A (pt) * 2003-02-17 2006-02-14 Altana Pharma Ag combinações e uso de compostos farmaceuticamente ativos selecionados
AR044129A1 (es) 2003-05-06 2005-08-24 Altana Pharma Ag Compuestos intermedios de imidazopiridina. proceso de preparacion.
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
CA2526566A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
EP1682133A1 (de) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo-1,2-a-pyridin-derivate zur behandlung von beschwerdefreiem gastroösophagealem reflux
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
WO2005058894A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
CN101027277A (zh) * 2004-07-23 2007-08-29 帝斯曼知识产权资产管理有限公司 (2r,3r)-2-羟基-3-氨基-3-芳基-丙酰胺和(2r,3r)-2-羟基-3-氨基-3-芳基-丙酸烷基酯的制备方法
AU2005291284A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
EP2452680B1 (de) 2009-07-09 2019-12-18 RaQualia Pharma Inc. Säurepumpenantagonist zur behandlung von mit unnormalen magen-darm-bewegungen assoziierten erkrankungen

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
JPH06502659A (ja) * 1991-05-31 1994-03-24 ファイザー インク 免疫抑制剤としてのラパマイシンプロドラッグの使用
DE4308095A1 (de) * 1993-03-13 1994-09-15 Hoechst Ag Prodrug-Derivate von Arzneimittelwirkstoffen mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
US6073004A (en) 1996-12-17 2000-06-06 Ericsson Inc. Emergency call initiator
BR9807883A (pt) * 1997-03-24 2000-02-22 Byk Gulden Lomberg Chem Fab Compostos de tetraidropirido
CA2289542A1 (en) * 1997-05-28 1998-12-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Fused dihydropyrans
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
WO2000017200A1 (en) * 1998-09-23 2000-03-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers
CA2349476A1 (en) * 1998-11-03 2000-05-11 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazonaphthyridines
CZ20023116A3 (cs) * 2000-03-29 2003-01-15 Altana Pharma Ag Alkylované imidazopyridinové sloučeniny

Also Published As

Publication number Publication date
ZA200207637B (en) 2004-04-08
DE60115466D1 (de) 2006-01-05
AU783633B2 (en) 2005-11-17
AU6016601A (en) 2001-10-08
NO20024662D0 (no) 2002-09-27
HK1056175A1 (en) 2004-02-06
KR100860627B1 (ko) 2008-09-29
HRP20020854A2 (en) 2004-12-31
BR0109483A (pt) 2003-06-10
US20030125327A1 (en) 2003-07-03
SK13852002A3 (sk) 2003-02-04
NO20024662L (no) 2002-09-27
CN1214030C (zh) 2005-08-10
WO2001072756A1 (en) 2001-10-04
US20040198764A1 (en) 2004-10-07
HUP0302331A2 (hu) 2003-12-29
DE60115466T2 (de) 2006-07-20
CN1426414A (zh) 2003-06-25
KR20020084262A (ko) 2002-11-04
US7189736B2 (en) 2007-03-13
EP1313740A1 (de) 2003-05-28
NZ520837A (en) 2005-01-28
ES2253376T3 (es) 2006-06-01
IL151200A0 (en) 2003-04-10
EA200200875A1 (ru) 2003-04-24
JP2003528878A (ja) 2003-09-30
DK1313740T3 (da) 2006-04-03
SI1313740T1 (sl) 2006-04-30
CA2404474A1 (en) 2001-10-04
MXPA02009551A (es) 2004-05-14
PL365116A1 (en) 2004-12-27
EA005597B1 (ru) 2005-04-28
IL151200A (en) 2009-11-18
SK286850B6 (sk) 2009-06-05
EP1313740B1 (de) 2005-11-30
CZ20023194A3 (cs) 2003-01-15

Similar Documents

Publication Publication Date Title
YU21401A (sh) Tetrahidropiridoetri
ATE332302T1 (de) Alkylierte imidazopyridinderivate
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
ATE386742T1 (de) Imidazonaphthyridine
ATE265455T1 (de) Tetrahydropyridoverbindungen
DE60127131D1 (de) Tricyclische imidazopyridine
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
ATE328883T1 (de) Imidazopyridin-8-one
IS8034A (is) Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla
EA200500903A1 (ru) Силиловые простые эфиры
PE61999A1 (es) Compuestos de tetrahidropiridina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1313740

Country of ref document: EP

REN Ceased due to non-payment of the annual fee